Anika Therapeutics

ANIK · NASDAQ

$20.44+$0.22 (+1.09%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $20.22

About ANIK

Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. The company is headquartered in Bedford, Massachusetts and currently employs 235 full-time employees. The firm is leveraging its core expertise in hyaluronic acid and implant solutions. The company partners with clinicians to provide minimally invasive products that restore active living for people around the world. The company is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. The company is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.

Employees: 235
Headquarters: Bedford, Massachusetts
Listed: May 16, 1985
Sector: Health Care
Industry: Biotechnology
Website: anika.com

Leadership

Anika Therapeutics executives
Name	Title	Since	Age
Cheryl Blanchard	—	2018	60
Stephen Griffin	—	2024	39
David Colleran	—	—	53
Ian Mcleod	—	—	59
John Henneman	—	—	63
Joseph Capper	—	—	61
Sheryl Conley	—	—	64
Gary Fischetti	—	—	64
William Jellison	—	—	67
Glenn Larsen	—	—	71
Stephen Richard	—	—	62
Matt Hall	—	2025	—

Revenue by product and region

Fiscal year ended Dec 31, 2025: $112.82M total revenue

By product

OEM Channel [Member]$64.41M57.1%
Commercial Channel [Member]$48.41M42.9%

By region

UNITED STATES$70.10M62.1%
Europe [Member]$22.21M19.7%
Other Location [Member]$20.55M18.2%

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Anika Therapeutics suppliers and customers
Company	Relationship	Country	Correlation
Johnson & Johnson JNJ	Supplier and customer	US	-0.58

Similar companies

Companies in the same industry as Anika Therapeutics

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.